Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States

Health Affairs Scholar(2023)10.1093/haschl/qxad013Source: DataRank Database

Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States is a research paper published in Health Affairs Scholar (2023). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 9.07)OA: goldTopics (22)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Bianca Rivera ORCID,Carla King ORCID,Bridget C.E. Dooling ORCID,Noa Krawczyk ORCID

Live enrichment

PubMed:38145115 OpenAlex:https://openalex.org/W4381380462

National Institutes of Health

Grant: K01DA055758

National Institutes of Health

Grant: 5K01DA055758-03

Beyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System Touchpoints

FWCI

9.07

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://academic.oup.com/healthaffairsscholar/advance-article-pdf/doi/10.1093/haschl/qxad013/50654129/qxad013.pdf

publisherhttps://academic.oup.com/healthaffairsscholar/advance-article-pdf/doi/10.1093/haschl/qxad013/50654129/qxad013.pdf

publisherhttps://academic.oup.com/healthaffairsscholar/article-pdf/1/1/qxad013/53894308/qxad013.pdf

journalhttps://doi.org/10.1093/haschl/qxad013

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38145115

Fields of Study

Opioid Use Disorder TreatmentSuicide and Self-Harm StudiesSubstance Abuse Treatment and Outcomes03 medical and health sciences0302 clinical medicine0305 other medical science

Keywords

BuprenorphineTelehealthOpioid use disorderLeverage (statistics)TelemedicineMedicinePublic healthHealth carePandemicBusinessNursingMedical emergencyPolitical scienceOpioidCoronavirus disease 2019 (COVID-19)Review Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being